Filter Results
Genomic Testing Reveals Gene Mutated in Pediatric Melanoma
Comprehensive clinical genomic testing of an adolescent patient, including whole genome sequencing, helped researchers identify mutations in a single gene that drive the most common childhood melanoma.
Modified Herpes Virus Increases Survival in Advanced Melanoma
A novel immunotherapy is showing long-term promise for the treatment of unresectable stage IIIB or stage IV melanoma in the form of a genetically modified herpes virus.
Patient Survival, QoL Hold Steady With Nivolumab & Ipilimumab Therapy
New therapies are showing significant promise for patients diagnosed with advanced metastatic melanoma—a disease with a historically poor prognosis.
Second Opinion Boosts Melanoma Diagnostic Accuracy
Unlike other cancer diagnoses that rely on objective measures, melanoma is often diagnosed based on a pathologist’s subjective assessment of a skin biopsy.
Skin Cancer Screening: Free Events May Fall Short
Free skin cancer screenings are critical educational tools to help attendees better understand the need for good sun protective habits and the potential risk of suspicious lesions.
Vaccine Slashes High-Risk Melanoma Recurrence
Researchers on the hunt for a cure for melanoma are one step closer with positive phase IIb results for a personalized cancer vaccine that shows a 50 percent reduction in recurrence for patients who completed the majority of the vaccination series.
A Call for Melanoma Biopsy Standards
Clinicians always want to do what is right for their patient, and that includes keeping invasive diagnostic procedures to a minimum.
Blood Test Tracks Melanoma Treatment Response
Clinicians treating patients with aggressive forms of skin cancer may soon have a simple tool to track treatment efficacy: a blood test.
Identifying a Mechanism of Resistance to BRAF Inhibitors in Melanoma
Melanoma is one of the most aggressive types of skin cancer, but recent advances in targeted therapies have improved the prognosis for many patients.